PURPOSE OF REVIEW: This article provides an overview of vascular cognitive impairment; discusses its epidemiology, subtypes, and associations with other neurodegenerative diseases; and reviews the diagnostic evaluation and management of these disorders. RECENT FINDINGS: Cerebrovascular disease is a common cause of dementia and frequently coexists with neurodegenerative causes. The heterogeneity of mechanisms leading to vascular cognitive impairment makes developing unifying clinical and research criteria difficult. Recognizing the neuroimaging hallmarks of different forms of vascular cognitive impairment can allow for individualized treatment and management. In individuals with mild vascular cognitive impairment, aerobic exercise appears to be a promising treatment but requires further investigation. SUMMARY: Vascular cognitive impairment can be caused by several mechanisms. While treating vascular risk factors is rational to prevent worsening of cognitive impairment, well-designed studies are needed to demonstrate efficacy.
PURPOSE OF REVIEW: This article provides an overview of vascular cognitive impairment; discusses its epidemiology, subtypes, and associations with other neurodegenerative diseases; and reviews the diagnostic evaluation and management of these disorders. RECENT FINDINGS:Cerebrovascular disease is a common cause of dementia and frequently coexists with neurodegenerative causes. The heterogeneity of mechanisms leading to vascular cognitive impairment makes developing unifying clinical and research criteria difficult. Recognizing the neuroimaging hallmarks of different forms of vascular cognitive impairment can allow for individualized treatment and management. In individuals with mild vascular cognitive impairment, aerobic exercise appears to be a promising treatment but requires further investigation. SUMMARY:Vascular cognitive impairment can be caused by several mechanisms. While treating vascular risk factors is rational to prevent worsening of cognitive impairment, well-designed studies are needed to demonstrate efficacy.
Authors: Jonathan Graff-Radford; Mekala R Raman; Alejandro A Rabinstein; Scott A Przybelski; Timothy G Lesnick; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; R Ross Reichard; Joseph E Parisi; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: JAMA Neurol Date: 2018-02-01 Impact factor: 18.302
Authors: Thomas G Beach; Jeffrey R Wilson; Lucia I Sue; Amanda Newell; Marissa Poston; Raquel Cisneros; Yoga Pandya; Chera Esh; Donald J Connor; Marwan Sabbagh; Douglas G Walker; Alex E Roher Journal: Acta Neuropathol Date: 2006-09-20 Impact factor: 17.088
Authors: Mekala R Raman; Gregory M Preboske; Scott A Przybelski; Jeffrey L Gunter; Matthew L Senjem; Prashanthi Vemuri; Matthew C Murphy; Melissa E Murray; Bradley F Boeve; David S Knopman; Ronald C Petersen; Joseph E Parisi; Dennis W Dickson; Clifford R Jack; Kejal Kantarci Journal: Neurology Date: 2014-05-02 Impact factor: 9.910
Authors: H Jokinen; A A Gouw; S Madureira; R Ylikoski; E C W van Straaten; W M van der Flier; F Barkhof; P Scheltens; F Fazekas; R Schmidt; A Verdelho; J M Ferro; L Pantoni; D Inzitari; T Erkinjuntti Journal: Neurology Date: 2011-05-04 Impact factor: 9.910
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Gabriel Gold; Constantin Bouras; Alessandra Canuto; Maria Fernanda Bergallo; François R Herrmann; Patrick R Hof; Pierre-André Mayor; Jean-Pierre Michel; Panteleimon Giannakopoulos Journal: Am J Psychiatry Date: 2002-01 Impact factor: 18.112
Authors: M Edip Gurol; J Alex Becker; Panagiotis Fotiadis; Grace Riley; Kristin Schwab; Keith A Johnson; Steven M Greenberg Journal: Neurology Date: 2016-09-07 Impact factor: 9.910
Authors: Mateusz Maciejczyk; Miłosz Nesterowicz; Anna Zalewska; Grzegorz Biedrzycki; Piotr Gerreth; Katarzyna Hojan; Karolina Gerreth Journal: Front Immunol Date: 2022-05-06 Impact factor: 8.786